IP Library Granted Patent US 9,550,064
Granted Patent B2
US 9,550,064 · App. 14/992,817 · Granted Jan 24, 2017

Apparatus and methods for feedback-based nerve modulation

Inventor: Adi Mashiach (Tel Aviv, IL)
A61N1/36075A61B5/0031A61B5/11A61B5/113A61B5/4818A61B5/682A61F5/566A61N1/05A61N1/0504A61N1/0514A61N1/0526A61N1/0529A61N1/0548A61N1/0551A61N1/0553A61N1/36A61N1/3601A61N1/36003A61N1/3605A61N1/3606A61N1/3611A61N1/36057A61N1/36117A61N1/36125A61N1/36135A61N1/36139A61N1/36146A61N1/3727A61N1/3756A61N1/3787A61N1/37211A61N1/37223A61N1/37229A61N1/37235A61N2/006A61N2/02A61B5/4519A61B5/6822A61B5/6833A61B5/6876A61B2562/164F04C2270/0421
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,550,064
App. No.
14/992,817
Granted
Jan 24, 2017
Kind
B2
Abstract

A device according to some embodiments may include a housing configured for location external to a body of a subject. The device may also include at least one processor associated with the housing and configured to communicate with a circuit implanted in the subject within proximity to a tongue of the subject, wherein the circuit is in electrical communication with at least one electrode, receive a physiological signal from the subject via the circuit, and send a control signal to the implanted circuit in response to the physiological signal, wherein the control signal is predetermined to activate neuromuscular tissue within the tongue.

Claims (43)

1. A hypertension therapy device, comprising:

a first antenna configured to communicate with a second antenna implanted in a body of a subject within proximity to at least one of a renal nerve, a baroreceptor, and a glossopharyngeal nerve;

a feedback circuit configured to communicate with the first antenna;

at least one processor configured to:

apply a sub-modulation control signal to the first antenna, the sub-modulation control signal inducing a secondary signal at the second antenna, the secondary signal in turn inducing a coupled signal at the first antenna;

receive, from the feedback circuit, the coupled signal generated at the first antenna;

determine a degree of coupling between the first antenna and the second antenna based on the coupled signal received from the feedback circuit; and

adjust a control signal sent to a circuit associated with the second antenna based on the degree of coupling, the control signal being configured to modulate the at least one of the renal nerve, the baroreceptor, and the glossopharyngeal nerve.

2. The hypertension therapy device of claim 1 , wherein the at least one processor is configured to generate and send the control signal to the circuit within a response time between 1 millisecond and 10 minutes.

3. The hypertension therapy device of claim 1 , wherein the first antenna is located external to the subject and is configured to send the control signal to the circuit implanted in the body of the subject from outside of the subject.

4. The hypertension therapy device of claim 1 , wherein at least one processor is configured to receive a physiological signal from the circuit through the second antenna and the first antenna, the physiological signal including at least one aspect indicative of blood pressure of the subject.

5. The hypertension therapy device of claim 4 , wherein blood pressure is detected via a blood pressure sensor.

6. The hypertension therapy device of claim 4 , wherein the at least one processor is further configured to:

receive a signal, indicative of the blood pressure, from a sensor remote from the circuit implanted in the body of the subject.

7. The hypertension therapy device of claim 4 , wherein the at least one processor is further configured to determine a degree of the blood pressure based on the physiological signal and vary a power level associated with the control signal based on the determined degree of the blood pressure.

8. The hypertension therapy device of claim 4 , wherein the at least one processor is further configured to determine a degree of the blood pressure based on the physiological signal and vary a duration of the control signal based on the determined degree of the blood pressure.

9. The hypertension therapy device of claim 1 , wherein the control signal is configured to perform at least one function chosen from the group consisting of stimulating the baroreceptor, down modulating the renal nerve, and stimulating the glossopharyngeal nerve.

10. The hypertension therapy device of claim 1 , wherein the at least one processor is further configured to send the control signal to the circuit implanted in the body of the subject to modulate nerve tissue to affect blood pressure.

11. A method for treating hypertension, comprising:

applying a sub-modulation control signal to a first antenna configured to communicate with a second antenna implanted in a body of a subject within proximity to at least one of a renal nerve, a baroreceptor, and a glossopharyngeal nerve, the sub-modulation control signal inducing a secondary signal at the second antenna, the secondary signal in turn inducing a coupled signal at the first antenna;

receiving, from a feedback circuit configured to communicate with the first antenna, the coupled signal generated at the first antenna;

determining a degree of coupling between the first antenna and the second antenna based on the coupled signal received from the feedback circuit; and

adjusting a control signal sent to a circuit associated with the second antenna based on the degree of coupling, the control signal being configured to modulate the at least one of the renal nerve, the baroreceptor, and the glossopharyngeal nerve.

12. The method of claim 11 , further comprising:

generating and sending the control signal to the circuit within a response time between 1 millisecond and 10 minutes.

13. The method of claim 11 , further comprising:

sending, through the first antenna located external to the subject, the control signal to the circuit implanted in the body of the subject from outside of the subject.

14. The method of claim 11 , further comprising:

receiving a physiological signal from the circuit through the second antenna and the first antenna, the physiological signal including at least one aspect indicative of blood pressure of the subject.

15. The method of claim 14 , further comprising:

detecting the blood pressure via a blood pressure sensor.

16. The method of claim 14 , further comprising:

receiving a signal, indicative of the blood pressure, from a sensor remote from the circuit implanted in the body of the subject.

17. The method of claim 14 , further comprising:

determining a degree of the blood pressure based on the physiological signal; and

varying a power level associated with the control signal based on the determined degree of the blood pressure.

18. The method of claim 14 , further comprising:

determining a degree of the blood pressure based on the physiological signal; and

varying a duration of the control signal based on the determined degree of the blood pressure.

19. The method of claim 11 ,

wherein the control signal is configured to perform at least one function chosen from the group consisting of stimulating the baroreceptor, down modulating the renal nerve, and stimulating the glossopharyngeal nerve.

20. The method of claim 11 , further comprising:

sending the control signal to the circuit implanted in the body of the subject to modulate nerve tissue to affect blood pressure.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2019
From: NYXOAH S.A.
To: MAN & SCIENCE S.A.
Reel/Frame 049305/0733 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2018
From: MASHIACH, ADI
To: NYXOAH SA
Reel/Frame 047148/0195 →
Continuity (8)
Continuation 14451362 · Aug 4, 2014
Division 14041520 · Sep 30, 2013
Division 13629686 · Sep 28, 2012
Continuation In Part 12642866 · Dec 21, 2009
Continuation In Part 12581907 · Oct 20, 2009
Provisional Application 61541651 · Sep 30, 2011
Provisional Application 61657424 · Jun 8, 2012
Related Publication 20160121122A1 · May 5, 2016